期刊文献+

ERRATUM TO:FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway

暂未订购
导出
摘要 Erratum to:SCIENCE CHINA Life Sciences,Volume 66,Issue 12:2805-2817(2023),https://doi.org/10.1007/s11427-023-2343-y.This paper contains errors in Figure 1B and Figure 5A,where the representative images of immunohistochemical staining of FSIP1 in TNBC tissues and Western blot band of Nanog in 231-WT and 231-F KO cells were misused.
出处 《Science China(Life Sciences)》 2025年第8期2501-2502,共2页 中国科学(生命科学英文版)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部